ACTA - Association of Canadian Travel Agencies

Click for COVID-19 Portal 
– 2021 ACTA Advocacy Priorities
– ACTA Member Alerts
– 2021 ACTA Government Submissions
– ACTA Ready to Travel Webinars/Podcasts
– Government Resources
– Human Resource Programs
– ACTAVision Newsletter
– Government Financial Aid Programs

WEBINAR: Visit Myrtle Beach, SC – WE ARE THE BEACH!
October 22, 2021, 11:00 AM EDT

The Myrtle Beach area continues to safely welcome visitors to its 60 miles, 100km of gorgeous coastline, now boasting new attractions, accommodations, dining options and more for 2021. Visit Myrtle Beach and its partner organizations continue to remind travelers to visit the destination responsibly and created a Healthy Travel section on VisitMyrtleBeach.com with the latest Covid-19 updates and mandates.

Register here.

View our Education Calendar here
Watch Webinars On-Demand here

Global Trade Associations Discuss the status of international travel
       


Watch video here.

ACTA Advocacy FundWe anticipate that a significant lobbying effort will need to continue for the coming months during and following the COVID-19 crisis to ensure Travel Agencies, their employees, and independent contractors are a priority. Your contribution is integral to securing the resources required to influence positive change in Regulatory reform for our industry at the Federal and Provincial levels.

Donate to the ACTA Advocacy Fund Today! 

ACTA calls on federal government to update travel advisories ACTA is calling on the federal government to urgently address the issues of global recognition of vaccinations – as well as reverting to country-specific risk-based travel advisories for fully vaccinated travellers. 

The recognition of Canadian vaccinations by other countries-- and out-of-date travel advisories-- are negatively impacting Canadian travellers and tourism business survival.

Global recognition of vaccinations essential to recovery
To ensure rapid and broad vaccination, the Canadian government promoted mixed vaccinations and the use of the AstraZeneca agent. 

Read full advisory here (Login Required)

Follow us on Social Media: